Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01317147 · ClinicalTrials.gov registry record
The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 12
- Enrollment target
NCT01317147 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 12 participants.
The verdict
NCT01317147 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The morbidly obese frequently present with mood and anxiety disorders, which are often treated with serotonin reuptake inhibitors (SRI) antidepressant drugs. The investigators hypothesized that gastric bypass surgery would decrease the absorption of SRI. The investigators also wished to determine whether a reduction in SRI levels would increase the likelihood of worsening depressive symptoms.
Interventions
- PROCEDURE Roux-en-Y gastric bypass (RYGBP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01317147
The ClinicalTrials.gov registry entry for NCT01317147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Roux-en-Y gastric bypass (RYGBP) is the first listed.
NCT01317147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01317147 about?
NCT01317147 is a clinical study titled "The Effect of Gastric Bypass on the Pharmacokinetics of Serotonin Reuptake Inhibitors". The morbidly obese frequently present with mood and anxiety disorders, which are often treated with serotonin reuptake inhibitors (SRI) antidepressant drugs. The investigators hypothesized that gastric bypass surgery would decrease the absorption of SRI. The investigators also wished to determine wh...
What is the current status of trial NCT01317147?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2007-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT01317147?
The interventions under investigation include: Roux-en-Y gastric bypass (RYGBP) (PROCEDURE).
Who is sponsoring clinical trial NCT01317147?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.